Evolution of antifungal drug resistance of the human-pathogenic fungus Candida albicans
- Weitere Titel
-
Evolution der Antimykotikaresistenz im humanpathogenen Pilz Candida albicans
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Würzburg, Universität Würzburg, Dissertation, 2021
- Schlagwort
-
Candida albicans
Drug resistance
Evolution
Evolution
Resistenz
Fitness
Candida albicans
Fluconazol
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2021
- Urheber
-
Popp, Christina
- Beteiligte Personen und Organisationen
-
Morschhäuser, Joachim
Ziebuhr, Wilma
Ebel, Frank
- DOI
-
10.25972/OPUS-24351
- URN
-
urn:nbn:de:bvb:20-opus-243515
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Popp, Christina
- Morschhäuser, Joachim
- Ziebuhr, Wilma
- Ebel, Frank
- Universität Würzburg
Entstanden
- 2021
Ähnliche Objekte (12)
Modulation of human monocytes by the pathogenic fungus Candida albicans
Candida albicans and Antifungal Peptides
Characterisation of the cell wall protein Pga29p in the human pathogenic fungus Candida albicans
Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
Antifungal activity of MAF-1A peptide against Candida albicans
Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
Serodiagnosis, biochemical reactivity and pathogenic mechanisms of Candida albicans
MFS transportome of the human pathogenic yeast Candida albicans
Interactions of Candida albicans with non-pathogenic gut bacteria
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens
Antifungal Activity of Synthetic Scorpion Venom-Derived Peptide Analogues Against Candida albicans
Modulation of human monocytes by the pathogenic fungus Candida albicans
Candida albicans and Antifungal Peptides
Characterisation of the cell wall protein Pga29p in the human pathogenic fungus Candida albicans
Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
Antifungal activity of MAF-1A peptide against Candida albicans
Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
Serodiagnosis, biochemical reactivity and pathogenic mechanisms of Candida albicans
MFS transportome of the human pathogenic yeast Candida albicans
Interactions of Candida albicans with non-pathogenic gut bacteria
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens
Antifungal Activity of Synthetic Scorpion Venom-Derived Peptide Analogues Against Candida albicans
Modulation of human monocytes by the pathogenic fungus Candida albicans
Candida albicans and Antifungal Peptides
Characterisation of the cell wall protein Pga29p in the human pathogenic fungus Candida albicans
Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
Antifungal activity of MAF-1A peptide against Candida albicans
Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
Serodiagnosis, biochemical reactivity and pathogenic mechanisms of Candida albicans
MFS transportome of the human pathogenic yeast Candida albicans
Interactions of Candida albicans with non-pathogenic gut bacteria
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens